University of North Dakota Home
Office Name
'
A to Z Index'Directory'Map
About OUr office
emerging technologies
available technologies
Information for faculty
Forms
Policies
Committees
other information
'
 
Pharmaceutical/Biotechnology
'

Active Ingredients

PB1

10/622,220

Yersinia species vaccine for the protection of an animal against of plague using YscF antigen.

PB2

Vaccines with improved properties for the protection against the plague.

-

Novel vaccines and therapeutics antibodies against select viruses and bacteria.

-

Small molecules/peptides for treatment of neurodegenerative diseases.

Tools/Model Systems

PB3

6,420,107

Assay for identifying anti-viral agents specific for protein coated double-stranded DNA viruses (broad claims).

PB4

Higher precision proteomics method for analysis of proteins and peptides in biological samples.

PB5

Recombinant system for screening biologically active proteins (non-exclusive only).

PB6

6,486,380

A transgenic mouse that produces increased insulin levels in pancreatic ß-cells .

PB7

5,777,098

DNA purification procedure for red blood cells.

Detection Tools & Systems

PB8

Yersinia YscF antibodies for detection of plague.

PB9

Nanodetection system for processing and rapid analysis of trace elements in agricultural biological samples.

PB10

High tier anitbodies against West Nile virus.

PB11 Novel medical device for OB/GYN Clinic.

 

 

 

 

 

 

 
Intellectual Property Commercialization & Economic Development
Twamley Hall Room 102
264 Centennial Drive Stop 7095
Grand Forks, ND 58202-7095
Telephone: 701-777-6772
Fax: 701-777-6708